angiotensin ii, des-phe(8)- has been researched along with tranexamic acid in 1 studies
Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (tranexamic acid) | Trials (tranexamic acid) | Recent Studies (post-2010) (tranexamic acid) |
---|---|---|---|---|---|
1,533 | 21 | 995 | 5,052 | 1,129 | 3,390 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
D'Armiento, JM; Eiseman, KA; Elisman, K; Fonseca, LD; Gerber, A; Goldklang, MP; Wagener, G | 1 |
1 trial(s) available for angiotensin ii, des-phe(8)- and tranexamic acid
Article | Year |
---|---|
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
Topics: Angiotensin I; Antifibrinolytic Agents; Blood Loss, Surgical; COVID-19; Double-Blind Method; Humans; Peptide Fragments; Pilot Projects; Tranexamic Acid; Treatment Outcome | 2022 |